Haemorheological factors and myocardial reperfusion in patients with ST-elevation myocardial infarction undergoing primary coronary intervention

Kardiologia Polska

Volumn 65, Issue 7, 2007, Pages 778-785

  Wasilewski, Jarosław ^a   Turczyński, Bolesław ^a   Słowińska, Ludmiła ^a   Kowalik, Violetta ^a   Osadnik, Tadeusz ^a   Poloński, Lech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Haemorheological factors; No reflow; PCI; STEMI

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; NARCOTIC ANALGESIC AGENT; NITRATE;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; DISEASE SEVERITY; ERYTHROCYTE AGGREGATION; FEMALE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; HYPERTENSION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MALE; SMOKING; ST SEGMENT ELEVATION;

EID: 34548405104     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Ellis SG, Lincoff AM, George BS, et al. Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Coron Artery Dis 1994; 5: 611-5.
2. Ellis SG, Da Silva ER, Spauldind CM, et al. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 2000; 139: 1046-53.
3. Camilleri JP, Joseph D, Fabiani JN, et al. Microcirculatory changes following early reperfusion in experimental myocardial infarction. Virchows Arch A Pathol Anat Histol 1976; 369: 315-33.
4. Yip HK, Chen MC, Chang HW, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest 2002; 122: 1322-32
5. Turczyński B, Słowińska L, Szczȩsny S, et al. Zmiany lepkości krwi i osocza w przebiegu ostrego zawału serca. Pol Arch Med Wewn 2002; 10: 971-8.
6. Sloop GD, Garber DW. The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clin Sci (Lond) 1997; 92: 473-9.
7. Woodward M, Rumley A, Tunstall-Pedoe H, et al. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Heaematol 1999; 104: 246-57.
8. Blann A, Bignell A, McCollum C. von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity. Atherosclerosis 1998; 139: 317-22.
9. Muggeo M, Calabro A, Businaro V, et al. Correlation of metabolic and hemorrheological parameters in diabetes and hyperlipidemia. Ric Clin Lab 1983; 13 (Suppl 3): 165-79.
10. Fuchs J, Weinberger I, Rotenberg Z, et al. Plasma viscosity in ischemic heart disease. Am Heart J 1984; 108; 435-9.
11. Ruhenstroth-Bauer G, Porz P, Boss N, et al. The erythrocyte aggregation value as a measure of the risk of myocardial infarction and arteriosclerosis of peripheral arteries. Clin Cardiol 1985; 8: 529-34.
12. Lowe GD, Lee AJ, Rumley A, et al. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997; 96: 168-73.
13. Hayakawa M, Kuzuya F. Effects of ticlopidine on erythrocyte aggregation in thrombotic disorders. Angiology 1991; 42: 747-53.
14. Di-Perri T, Guerrini M, Pasini FL, et al. Hemorheological factors in the pathophysiology of acute and chronic cerebrovascular disease. Cephalagia 1985; 5 (Suppl 2): 71-7.
15. Turczyński B, Michalska-Małecka K, Słowińska L, et al. Correlations between the severity of retinopathy in diabetic patients and whole blood and plasma viscosity. Clin Hemorheol Microcirc 2003; 29: 129-37.
16. Fowkes FG, Lowe GD, Rumley A, et al. The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years. Eur Heart J 1993; 14: 597-601.
17. Lo-Presti R, Sinagra D, Montana M, et al. Haemorheological profile in metabolic Syndrome. Clin Hemorheol Microcirc 2002; 26: 241-7.
18. Gordge MP, Faint RW, Rylance PB, et al. Abnormal blood rheology in progressive renal failure: a factor in non-immune glomerular injury? Nephrol Dial Transplant 1988; 3: 257-62.
19. Price JF, Lee AJ, Fowkers FG, et al. Influence of high-density lipoprotein cholesterol and rheological factors on the sex difference in cardiovascular disease. J Cardiovasc Risc 2000; 7: 49-56.
20. Doring A, Frohlich M, Lowel H, et al. Third generation oral contraceptive use and cardiovascular risk factors. Atherosclerosis 2004; 172: 281-6.
21. Fröchlich M, Sund M, Löwel H, et al. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J 2003; 24: 1365-72.
22. Turczyński B, Słowińska L, Szyguła J, et al. Lepkość krwi i osocza u chorych z jedno- i wielonaczyniowa̧ choroba̧ wieńcowa̧. Pol Arch Med Wewn 2000; 104: 475-81.
23. Junker R, Heinrich J, Ulbrich H, et al. Relationship between plasma viscosity and the severity of coronary heart disease. Arterioscler Thromb Vasc Biol 1998; 18: 870-5.
24. Koenig W, Sund M, Filipiak B, et al. Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992. Arterioscler Thromb Vasc Biol 1998; 18: 768-72.
25. Baker IA, Pickering J, Elwood PC, et al. Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: evidence from the Caerphilly and Speedwell cohort. Thromb Haemost 2002; 87: 421-5.
26. Neumann FJ, Katus HA, Hoberg E, et al. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Br Heart J 1991; 66: 425-30.
27. Burr ML, Holliday RM, Fehily AM, et al. Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). Eur Heart J 1992; 13: 166-70.
28. Sargento L, Saldanha C, Monteiro J, et al. Evidence of prolonged disturbances in the haemostatic, hemorheologic and inflammatory profiles in transmural myocardial infarction survivors. Thromb Haemost 2003; 89: 892-903.
29. Empen K, Geiss HC, Lehrke M, et al. Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia. Nutr Metab Cardiovasc Dis 2003; 13: 87-92.
30. Frost R, Otto C, Geiss HC, et al. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia. Am J Cardiol 2001; 87: 44-8.
31. Muravyov AV, Yakusevich VV, Surovaya L, et al. The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients. Clin Hemorheol Microcirc 2004; 31: 251-6.
32. Mellwig KP, Baller D, Schmidt HK, et al. Myocardial perfusion under H.E.L.P.-apheresis. Objectification by PET. Z Kardiol 2003; 92 (Suppl 3): III30-7.
33. Arntz HR, Perchalla G, Roll D, et al. Blood rheology in acute myocardial infarction: effects of high-dose i.v. streptokinase compared to placebo. Eur Heart J 1992; 13: 257-80.
34. Ben-Ami R, Sheinman G, Yedgar S, et al. Thrombolytic therapy reduces red blood cell aggregation in plasma without affecting intrinsic aggregability. Thromb Res 2002; 105: 487-92.
35. Penco M, Romano S, Dagianti A Jr, et al. Modifications of whole blood filterability during acute myocardial infarction. Clin Hemorheol Microcirc 2000; 22: 153-9.
36. Golino P, Maroko PR, Carew TE. The effect of acute hypercholesterolemia on myocardial infarct size and the noreflow phenomenon during coronary occlusion-reperfusion. Circulation 1987; 75: 292-8.
37. Lazar HL, Bao Y, Zhang Y, et al. Pretreatment with statins enhances myocardial protection during coronary revascularization. J Thorac Cardiovasc Surg 2003; 125: 1037-42.
38. Dobrzycki S, Kozuch M, Kamiński K, et al. High cholesterol in patients with ECG signs of no-reflow after myocardial infarction. Rocz Akad Med Białymst 2003; 48: 118-22.
39. Ga̧sior M, Gierlotka T, Lekston A, et al. Relation between time of pain and long-therm outcome in patients with acute myocardial infarction transferred to primary angioplasty or angioplasty facilitated with thrombolysis. J Am Coll Cardiol 2004; 43 (Suppl A): 264A.
40. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 102: 125-30.
41. Hardeman MR, Dobbe JG, Ince C. The Laser-assisted Optical Rotational Cell Analyzer (LORCA) as red blood cell aggregometer. Clin Hemorheol Microcirc 2001; 25: 1-11.
42. Baskurt OK, Temiz A, Meiselman HJ. Effect of superoxide anions on red blood cell rheologic properties. Free Radic Biol Med 1998; 24: 102-10.
43. Mo J, Fan J, Guo Z, et al. A new hypothesis about the relationship between free radical reactions and hemorheological properties in vivo. Med Hypotheses 1993; 41: 516-20.
44. Kesmarky G, Toth K, Vajda G, et al. Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty. Clin Hemorheol Microvasc 2001; 24: 33-41.
45. Fusman G, Mardi T, Justo D, et al. Red blood cell adhesiveness/ aggregation, C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors. Am J Cardiol 2002; 90: 561-3.
46. Moriarty PM, Gibson CA, Kensey KR, et al. Effect of low-density lipoprotein cholesterol apheresis on blood viscosity. Am J Cardiol 2004; 93: 1044-6.
47. Julius U, Metzler W, Pietzsch J, et al. Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP. Int J Artif Organs 2002; 25: 1180-8.
48. Walzl M, Lechner H, Walzl B, et al. Improved neurological recovery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen. Stroke 1993; 24: 1447-51.